Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1996-12-26
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0028-2766
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
73
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
486-7
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8832615-Adult,
pubmed-meshheading:8832615-Biological Markers,
pubmed-meshheading:8832615-Endothelium, Vascular,
pubmed-meshheading:8832615-Female,
pubmed-meshheading:8832615-Humans,
pubmed-meshheading:8832615-Kidney Transplantation,
pubmed-meshheading:8832615-Male,
pubmed-meshheading:8832615-Thrombomodulin
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Circulating thrombomodulin as a molecular marker of endothelium damage in renal transplant recipients.
|
| pubmed:publicationType |
Letter,
Clinical Trial
|